Author(s): Warrier R, Chauhan A
Abstract Share this page
Abstract Rapid strides have been made in the field of hematology, and advances in immune thrombocytopenic purpura (ITP) management are no exception. From idiopathic to immune, the changed nomenclature is itself a testimonial to the growing awareness and improvements in the management of ITP. We discuss the pathophysiology, clinical presentation, and current management of this common pediatric disorder and summarize current guidelines for ITP treatment.
This article was published in Ochsner J
and referenced in Journal of Nephrology & Therapeutics